Company intelligence / Profile preview

Bouchara Recordati

Puteaux, Île-de-France, Francerecordatirareseases.com ↗
Ownership
Private
Employees
~214
Development stage
Other
01

Overview

Bouchara Recordati is a French subsidiary of the global pharmaceutical group Recordati. It develops and markets both branded and generic drugs in specialty care, primary care, and rare diseases. The company has a strong commercial presence in Europe and emerging markets. Its pipeline includes both proprietary products developed in-house as well as licensed-in assets. Recent years have seen expansion into rare disease therapeutics with several products approved for orphan indications.

Therapeutic areas
PsychiatryCardiovascularNephrologyEndocrinologyRare DiseasesInfectious Diseases
Modalities
Small moleculeBiologic
Industry
Biotech
02

Drug pipeline

1 asset

Polydexa

Unknown
03

Partnerships

Gedeon Richter Plc (commercialization of cariprazine/Reagila®)Sanofi (acquisition of rights to Enjaymo®)Assistance Publique – Hôpitaux de Paris (development collaboration on Maple Syrup Urine Disease therapy)

Beyond the preview

Go deeper on Bouchara Recordati.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bouchara Recordati.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call